Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-03

Clinical Trial Update: Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

View source ↗

Summary

This is an implementation study evaluating lenacapavir as pre-exposure prophylaxis for HIV prevention, currently recruiting. The study aims to assess real-world…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Status: RECRUITING